Seeking advice for biotech ER -> IB

Bg: ER associate with ~4yr experience covering therapeutics but without own coverage at a large bank. 

Throughout my years, I strongly feel like I am more closed to or more enjoy interacting with my covered or vetted company management teams vs. buy-side clients. I personally don't believe I have a cold/killer personality often equipped by successful therapeutic investors even though I like taking risks (so I want to do what I am good at and love doing vs. continue my somewhat mediocre career). 

Definitely don't want to pursue an MBA...but wondering how I should switch to an HC IB associate role at another BB/leading MM or even EB that does not have a balance sheet


WSO Elite Modeling Package

  • 6 courses to mastery: Excel, Financial Statement, LBO, M&A, Valuation and DCF
  • Elite instructors from top BB investment banks and private equity megafunds
  • Includes Company DB + Video Library Access (1 year)

Comments (1)

Nov 21, 2021 - 11:43am

Nesciunt non illum ad in omnis eum. Quia sint cum rerum eligendi ea modi sint. Omnis est et quod aut sit quod. Necessitatibus esse illo sequi iure fugit esse neque.

Deserunt sequi earum blanditiis rem quas ratione ut sint. Eius voluptatum perferendis minima enim.

Start Discussion

Total Avg Compensation

November 2021 Investment Banking

  • Director/MD (10) $853
  • Vice President (40) $360
  • Associates (234) $234
  • 2nd Year Analyst (144) $156
  • 3rd+ Year Analyst (34) $154
  • Intern/Summer Associate (107) $146
  • 1st Year Analyst (513) $136
  • Intern/Summer Analyst (393) $83